2. 動脈硬化のハイリスク病態とその分子基盤

Saved in:
Bibliographic Details
Published in日本内科学会雑誌 Vol. 95; no. Suppl; pp. 61a - 63a
Main Author 山田, 信博
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本内科学会 2006
Subjects
Online AccessGet full text
ISSN0021-5384
1883-2083
DOI10.2169/naika.95.61a

Cover

Author 山田, 信博
Author_xml – sequence: 1
  fullname: 山田, 信博
  organization: 筑波大学
BookMark eNpFkMtKw0AYhQepYK3d-QC-QOLcMp2AGyleCgUX6jr8M5loaq0lqQuXvUmhgm7UhYgIXYh4WevrDDE-hkVFV-fA-ThwzjwqtI5aBqFFgl1KhL_cgvgAXN9zBYEZVCRSModiyQqoiDEljsckn0PlNI0V5kx4kjBeRCvUXcrGl5-DUX7_lJ1d2e6L7Z_b3sT2H23vzfZe8-vhx3Bsuw-2eztNs9Fp9nyR3b3nN5MFNBtBMzXlXy2h3fW1neqmU9_aqFVX606DiAp2KiRSVGmhNITAidaacWWoZIx6VFYkBxKGEcgIUxAkMspEVEqupe9RbQRjJVT76W2kHdgzQTuJDyE5CSDpxLppgu_pge8F28ftdvPfTJ_4Y_Q-JEED2BdEA24o
ContentType Journal Article
Copyright 2006 一般社団法人 日本内科学会
Copyright_xml – notice: 2006 一般社団法人 日本内科学会
DOI 10.2169/naika.95.61a
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1883-2083
EndPage 63a
ExternalDocumentID article_naika_95_Suppl_95_Suppl_61a_article_char_ja
GroupedDBID 2WC
ALMA_UNASSIGNED_HOLDINGS
DIK
F5P
JSF
OK1
RJT
ZXP
ID FETCH-LOGICAL-j1670-71fb2bc6bcada41ccc34be28332528784a1ddfa8f02a61febef2884c8952ce633
ISSN 0021-5384
IngestDate Wed Sep 03 06:29:04 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue Suppl
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j1670-71fb2bc6bcada41ccc34be28332528784a1ddfa8f02a61febef2884c8952ce633
OpenAccessLink https://www.jstage.jst.go.jp/article/naika/95/Suppl/95_Suppl_61a/_article/-char/ja
ParticipantIDs jstage_primary_article_naika_95_Suppl_95_Suppl_61a_article_char_ja
PublicationCentury 2000
PublicationDate 20060000
PublicationDateYYYYMMDD 2006-01-01
PublicationDate_xml – year: 2006
  text: 20060000
PublicationDecade 2000
PublicationTitle 日本内科学会雑誌
PublicationTitleAlternate 日内会誌
PublicationYear 2006
Publisher 一般社団法人 日本内科学会
Publisher_xml – name: 一般社団法人 日本内科学会
References 2) Abe H, et al : Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest 101 : 1784-1788, 1998.
4) Ide T, et al : SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nature Cell Biology 6 (4) : 351-357, 2004.
5) Yoshikawa T, et al : Identification of Liver X Receptor-Retinoid X Receptor as an Activator of the Sterol Regulatory Element-Binding Protein 1c Gene Promoter. Mol Cell Biol 21 : 2991-3000, 2001.
6) Ide T, et al : Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Mol Endocrinol 17 : 1255-1267, 2003.
3) Chen Z, et al : Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice : pleiotropic effects on CD36 expression and HDL. Arterioscler Thromb Vasc Biol 21 : 372-375, 2001.
7) Matsuzaka T, et al : Insulin-Independent Induction of Sterol Regulatory Element-Binding Protein-1c Expression in the Livers of Streptozotocin-Treated Mice. Diabetes 53 : 560-569, 2004.
1) Yamada N, et al : Increased risk factors for coronary artery disease in Japanese subjects with hyperinsulinemia or glucose intolerance. Diabetes Care 17 : 107, 1994.
References_xml – reference: 4) Ide T, et al : SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nature Cell Biology 6 (4) : 351-357, 2004.
– reference: 6) Ide T, et al : Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Mol Endocrinol 17 : 1255-1267, 2003.
– reference: 1) Yamada N, et al : Increased risk factors for coronary artery disease in Japanese subjects with hyperinsulinemia or glucose intolerance. Diabetes Care 17 : 107, 1994.
– reference: 2) Abe H, et al : Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest 101 : 1784-1788, 1998.
– reference: 3) Chen Z, et al : Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice : pleiotropic effects on CD36 expression and HDL. Arterioscler Thromb Vasc Biol 21 : 372-375, 2001.
– reference: 5) Yoshikawa T, et al : Identification of Liver X Receptor-Retinoid X Receptor as an Activator of the Sterol Regulatory Element-Binding Protein 1c Gene Promoter. Mol Cell Biol 21 : 2991-3000, 2001.
– reference: 7) Matsuzaka T, et al : Insulin-Independent Induction of Sterol Regulatory Element-Binding Protein-1c Expression in the Livers of Streptozotocin-Treated Mice. Diabetes 53 : 560-569, 2004.
SSID ssib043658134
ssj0066765
ssib002821954
ssib005879745
ssib007485360
ssib058493862
ssib000940260
ssib002484664
Score 1.6933439
SourceID jstage
SourceType Publisher
StartPage 61a
SubjectTerms インスリン抵抗性
メタボリックシンドローム
動脈硬化
糖尿病
転写調節
Title 2. 動脈硬化のハイリスク病態とその分子基盤
URI https://www.jstage.jst.go.jp/article/naika/95/Suppl/95_Suppl_61a/_article/-char/ja
Volume 95
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本内科学会雑誌, 2006/02/20, Vol.95(Suppl), pp.61a-63a
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1883-2083
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib007485360
  issn: 0021-5384
  databaseCode: KQ8
  dateStart: 19130101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals - Free Access to All
  customDbUrl:
  eissn: 1883-2083
  dateEnd: 20061231
  omitProxy: true
  ssIdentifier: ssj0066765
  issn: 0021-5384
  databaseCode: DIK
  dateStart: 19130101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NixMxFB_WFcSL-Inf9GBOy9TmYzIJeMl0W1ZlvbgLexsm0-mhhyrSvXhr15WFFfSiHkRE2IOIH2f9d4Za_wzfy0zbKexBizAMIR-_5OVlJr-E5D3Pu8W6LLUybPjMisQXLGn4NgulnwJZ4CxtZMziReHNB3JjW9zbCXZWTjysnFraHdh6-vTYeyXLaBXiQK94S_YfNDsDhQgIg37hDRqG91_pmNXXSCsgKiI6IC1FFBBDRVohMZSYpktqEi1JiwNhJKblAvC0XYARI8oYY8qYSE-T2oijQ6IAWeIbailxVBnQ6xXkAKtWEgNmnegGBnSbRMbhRFBXlQcjJoAbB66b09a6irD9UISWUAYwBYlAEIDSCIVJCtusZlu8mDei-GBtkL2BY8cVbGNvIDi0yixucswGpMuo8NQH9qJyzQmxeyInGTafY0sj7npaoFiRWVtOiupEwagPc0HRNVkxNyjFYfgVfnemk0fhIbT8SJwj1spsIGlSIRaSJ8fNWYxKNPnaxxtjdR3UZ4UWrICXYyx22WIdxK6ueQBKxdM8eF8v7sGi4STDTSpcKdy9X-HUAu3IVTiaWnAxAGtwWrURGKhQV10ihAIY3ry84MBh6dzGIBBazZWc2XDDM9SFG5GyR4vbJyj17arMwAB7sB6anqV09G7rrHemXJfVTCHcOW-ll5z3Tm2WJ08ueHdYvTY-fP372cHk45fxizf58Fu-9zIfHeV7n_PRj3z0ffJ2_9f-YT78lA_fQ-r44Pn466vxh5-Td0cXve12a6u54ZeeR_wexR9XSLuW2VTaNOkkgqZpyoXNgIlzFjAVKpHQTqebqG6DJZJ24UfYZUqJVOmApZnk_JK32n_Uzy57tZBmQWIV09LNj6lWVtggs8CVOXLpK15UyB0_LszLxEuo-ur_ALnmnZ7vL173VgdPdrMbwLgH9qYbQX8A_Yiwfw
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2.+%E5%8B%95%E8%84%88%E7%A1%AC%E5%8C%96%E3%81%AE%E3%83%8F%E3%82%A4%E3%83%AA%E3%82%B9%E3%82%AF%E7%97%85%E6%85%8B%E3%81%A8%E3%81%9D%E3%81%AE%E5%88%86%E5%AD%90%E5%9F%BA%E7%9B%A4&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E5%B1%B1%E7%94%B0%2C+%E4%BF%A1%E5%8D%9A&rft.date=2006&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5384&rft.eissn=1883-2083&rft.volume=95&rft.issue=Suppl&rft.spage=61a&rft.epage=63a&rft_id=info:doi/10.2169%2Fnaika.95.61a&rft.externalDocID=article_naika_95_Suppl_95_Suppl_61a_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5384&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5384&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5384&client=summon